Accuracy of glucose monitors during surgery in youth with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests how well continuous glucose monitors (CGMs) work during surgery and hospital stays in young people with type 1 diabetes. It aims to make sure these devices give accurate readings when they are most needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 26 years old.
- You have type 1 diabetes and use insulin.
- You already wear a continuous glucose monitor (CGM) at home, like Dexcom, Freestyle Libre, or Medtronic Guardian.
- You are willing to share your CGM data with the study team.
- You are not pregnant.
- You are not taking the medication hydroxyurea.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a continuous glucose monitor (CGM) to standard finger-stick blood sugar checks in adults with type 1 diabetes while they are in the hospital and after they go home. It aims to see if using a CGM leads to better blood sugar control during and after hospitalization.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
This study tests whether a small continuous glucose monitor (a sensor that checks your sugar levels all the time) can be used easily in youth who are in the hospital. It may help doctors track your blood sugar closely without needing as many finger sticks.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.